197 related articles for article (PubMed ID: 18245468)
1. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.
Yarosh W; Barrientos T; Esmailpour T; Lin L; Carpenter PM; Osann K; Anton-Culver H; Huang T
Cancer Res; 2008 Feb; 68(3):693-9. PubMed ID: 18245468
[TBL] [Abstract][Full Text] [Related]
2. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator.
Lingbeek ME; Jacobs JJ; van Lohuizen M
J Biol Chem; 2002 Jul; 277(29):26120-7. PubMed ID: 12000749
[TBL] [Abstract][Full Text] [Related]
3. TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53.
Platonova N; Scotti M; Babich P; Bertoli G; Mento E; Meneghini V; Egeo A; Zucchi I; Merlo GR
Cell Tissue Res; 2007 May; 328(2):301-16. PubMed ID: 17265068
[TBL] [Abstract][Full Text] [Related]
4. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract][Full Text] [Related]
5. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
[TBL] [Abstract][Full Text] [Related]
6. TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence.
Brummelkamp TR; Kortlever RM; Lingbeek M; Trettel F; MacDonald ME; van Lohuizen M; Bernards R
J Biol Chem; 2002 Feb; 277(8):6567-72. PubMed ID: 11748239
[TBL] [Abstract][Full Text] [Related]
7. TBX2 and TBX3: the special value for anticancer drug targets.
Lu J; Li XP; Dong Q; Kung HF; He ML
Biochim Biophys Acta; 2010 Dec; 1806(2):268-74. PubMed ID: 20624445
[TBL] [Abstract][Full Text] [Related]
8. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome.
Carlson H; Ota S; Campbell CE; Hurlin PJ
Hum Mol Genet; 2001 Oct; 10(21):2403-13. PubMed ID: 11689487
[TBL] [Abstract][Full Text] [Related]
9. TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model.
Liu J; Esmailpour T; Shang X; Gulsen G; Liu A; Huang T
BMC Dev Biol; 2011 Oct; 11():65. PubMed ID: 22039763
[TBL] [Abstract][Full Text] [Related]
10. p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb.
Zeng Y; Kotake Y; Pei XH; Smith MD; Xiong Y
Cancer Res; 2011 Apr; 71(7):2781-92. PubMed ID: 21447739
[TBL] [Abstract][Full Text] [Related]
11. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
12. [Tbx3 upregulation may be one of the malignant biomarkers of breast cancer].
Chen ZH; Lv GM; Ji TH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):765-7. PubMed ID: 19403417
[TBL] [Abstract][Full Text] [Related]
13. The role of Tbx2 and Tbx3 in mammary development and tumorigenesis.
Rowley M; Grothey E; Couch FJ
J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):109-18. PubMed ID: 15300007
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer.
Amir S; Simion C; Umeh-Garcia M; Krig S; Moss T; Carraway KL; Sweeney C
Br J Cancer; 2016 May; 114(10):1125-34. PubMed ID: 27100732
[TBL] [Abstract][Full Text] [Related]
15. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
16. TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines.
Fan W; Huang X; Chen C; Gray J; Huang T
Cancer Res; 2004 Aug; 64(15):5132-9. PubMed ID: 15289316
[TBL] [Abstract][Full Text] [Related]
17. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
Vance KW; Carreira S; Brosch G; Goding CR
Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
[TBL] [Abstract][Full Text] [Related]
18. TBX3 promotes human embryonic stem cell proliferation and neuroepithelial differentiation in a differentiation stage-dependent manner.
Esmailpour T; Huang T
Stem Cells; 2012 Oct; 30(10):2152-63. PubMed ID: 22865636
[TBL] [Abstract][Full Text] [Related]
19. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
20. PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.
Mowla S; Pinnock R; Leaner VD; Goding CR; Prince S
Biochem J; 2011 Jan; 433(1):145-53. PubMed ID: 20942798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
